|
Frenck Jr, Robert W; Belshe, Robert; Brady, Rebecca C et al. (2011) Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine 29:5666-74
|
|
Baer, Jane; Santiago, Felix; Yang, Hongmei et al. (2010) B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant. Vaccine 28:907-15
|
|
Crompton, Peter D; Mircetic, Marko; Weiss, Greta et al. (2009) The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J Immunol 182:3318-26
|
|
Brady, Rebecca C; Treanor, John J; Atmar, Robert L et al. (2009) Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine 27:5091-5
|
|
Pichichero, Michael E; Gentile, Angela; Giglio, Norberto et al. (2009) Mercury levels in premature and low birth weight newborn infants after receipt of thimerosal-containing vaccines. J Pediatr 155:495-9
|
|
Keitel, Wendy A; Treanor, John J; El Sahly, Hana M et al. (2009) Evaluation of a plasmid DNA-based anthrax vaccine in rabbits, nonhuman primates and healthy adults. Hum Vaccin 5:536-44
|
|
Pichichero, Michael E; Gentile, Angela; Giglio, Norberto et al. (2008) Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines. Pediatrics 121:e208-14
|
|
Zangwill, Kenneth M; Treanor, John J; Campbell, James D et al. (2008) Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis 197:580-3
|
|
Talbot, H Keipp; Keitel, Wendy; Cate, Thomas R et al. (2008) Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine 26:4057-61
|
|
Goji, Nega Ali; Nolan, Carrie; Hill, Heather et al. (2008) Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 198:635-41
|
Showing the most recent 10 out of 15 publications
